-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Initiates Coverage On ANI Pharmaceuticals with Perform Rating, Announces Price Target of $85

Benzinga·09/23/2026 12:03:29
Listen to the news
Oppenheimer analyst Les Sulewski initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Perform rating and announces Price Target of $85.